Meghmani Organics · NSE: MOL · BSE: 543331
Q4 FY25 results · Jan–Mar 2025
Meghmani Organics reported revenue from operations of ₹553.46 crore (up 35.0% from Q4 FY24) and net profit of ₹19.82 crore for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 553.46 | 410.03 | +35.0% | 568.51 | −2.6% |
| Other income | 13.88 | 8.95 | +55.1% | 9.14 | +51.9% |
| Total income | 567.34 | 418.98 | +35.4% | 577.65 | −1.8% |
| Profit before tax | 30.55 | (14.32) | Turned profit | 7.41 | +312.3% |
| Net profit for the period | 19.82 | (17.96) | Turned profit | (4.39) | Turned profit |
| EPS, basic (₹) | 0.78 | (0.71) | Turned profit | (0.17) | Turned profit |
| Net margin (%) | 3.6 | -4.4 | -0.8 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 502.10 | 399.81 | +25.6% | 558.03 | −10.0% |
| Other income | 14.42 | 13.93 | +3.6% | 9.97 | +44.6% |
| Total income | 516.52 | 413.73 | +24.8% | 568.01 | −9.1% |
| Profit before tax | 43.62 | 1.90 | 23x | 42.12 | +3.6% |
| Net profit for the period | 33.97 | (0.40) | Turned profit | 30.18 | +12.6% |
| EPS, basic (₹) | 1.34 | (0.02) | Turned profit | 1.19 | +12.9% |
| Net margin (%) | 6.8 | -0.1 | 5.4 |
Consolidated
- Filed with BSE
- 10 May 2025, 17:39 IST
- Board meeting
- 10 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 May 2025, 17:39 IST
- Board meeting
- 10 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE